Canaryhealthtech
1 known investors
Canary Health Technology develops handheld, smartphone-sized nanoparticle biosensor devices that analyze volatile organic compounds in exhaled breath and saliva, using AI-powered pattern recognition to detect diseases such as COVID-19 and lung cancer and to monitor therapy response. Its point-of-care platforms — including the Pelican ultra-rapid COVID-19 test, ASU DETECT CV-19, and the G2 Track medication-adherence tool — are aimed at doctors and clinicians in primary healthcare settings.
AI & Machine LearningHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Canaryhealthtech do?
- Canary Health Technology develops handheld, smartphone-sized nanoparticle biosensor devices that analyze volatile organic compounds in exhaled breath and saliva, using AI-powered pattern recognition to detect diseases such as COVID-19 and lung cancer and to monitor therapy response. Its point-of-care platforms — including the Pelican ultra-rapid COVID-19 test, ASU DETECT CV-19, and the G2 Track medication-adherence tool — are aimed at doctors and clinicians in primary healthcare settings.
- Who are Canaryhealthtech's investors?
- Canaryhealthtech's investors include East Post Road Ventures.